Hyperfine (HYPR)
(Delayed Data from NSDQ)
$1.07 USD
+0.08 (8.07%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $1.07 0.00 (0.00%) 6:28 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HYPR 1.07 +0.08(8.07%)
Will HYPR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HYPR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HYPR
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue Estimates
HYPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should Know
Down -19% in 4 Weeks, Here's Why Hyperfine (HYPR) Looks Ripe for a Turnaround
Hyperfine, Inc. (HYPR) Reports Q4 Loss, Lags Revenue Estimates
Other News for HYPR
Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
Clinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer’s Association International Conference
Hyperfine announces two presentations at AAIC
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India